Preoperative medical therapy for acromegaly: current knowledge and clinical significance
Dan He, Qinyi Wang, Zhifeng Sheng, Guohua Li · 2026
Read Preoperative medical therapy for acromegaly: current knowledge and clinical significance by Dan He, Qinyi Wang, Zhifeng Sheng, Guohua Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12807991.txt.
Description
He, Wang, Sheng, and Li review drug therapy before surgery for acromegaly, in a narrative review from twenty twenty-five. Too much growth hormone, from tumors of the pituitary gland, drives this long-term hormone disorder. Surgery often fails to cure large tumors that invade nearby tissue in full. Drugs given before surgery aim to lift the odds that the disease stays away after it.
First-generation somatostatin drugs are the agents most studied for use before surgery so far. Their effect on whether the disease stays away after surgery stays in dispute. New drugs and targets in the body's molecules are reshaping the field step by step. Imaging and markers in tissue and blood promise better picks of patients and better sorting of them. New forms of drugs may widen the choices for people who are poor fits for surgery.
Catalog record
| CREATOR | Dan He, Qinyi Wang, Zhifeng Sheng, Guohua Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |